ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

NCAB Subcommittee Calls For Review Of Organ Site Program, Consideration Of One For Lung Cancer

May 1, 1981

AIDS Cachexia Drug Stabilizes Body Weight, Muscle Mass

March 29, 2013

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

November 3, 2006

NCI-Approved Clinical Trials Listed For June 2001

July 27, 2001

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

In Brief: President Asks $700 Million for NCI In 1977; Appropriation Delay Halts New Research Funds

January 2, 1976